IRIS
PIVONELLO, ROSARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.199
EU - Europa 3.324
AS - Asia 3.044
AF - Africa 105
SA - Sud America 15
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.698
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.034
SG - Singapore 1.291
IT - Italia 1.004
CN - Cina 911
HK - Hong Kong 670
NL - Olanda 430
FI - Finlandia 379
DE - Germania 345
SE - Svezia 340
IE - Irlanda 313
UA - Ucraina 190
CA - Canada 149
CI - Costa d'Avorio 96
GB - Regno Unito 88
FR - Francia 83
RU - Federazione Russa 70
IN - India 43
TR - Turchia 42
IR - Iran 22
ES - Italia 20
VN - Vietnam 16
CZ - Repubblica Ceca 14
MX - Messico 14
BE - Belgio 13
IQ - Iraq 10
ID - Indonesia 9
RO - Romania 9
AU - Australia 7
JO - Giordania 7
AT - Austria 6
PL - Polonia 5
EG - Egitto 4
EU - Europa 4
PH - Filippine 4
AR - Argentina 3
BR - Brasile 3
LK - Sri Lanka 3
NO - Norvegia 3
PK - Pakistan 3
BO - Bolivia 2
CH - Svizzera 2
CL - Cile 2
DK - Danimarca 2
DZ - Algeria 2
EC - Ecuador 2
GR - Grecia 2
IL - Israele 2
JP - Giappone 2
KE - Kenya 2
KR - Corea 2
MY - Malesia 2
PE - Perù 2
SI - Slovenia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BG - Bulgaria 1
CO - Colombia 1
CR - Costa Rica 1
HR - Croazia 1
LB - Libano 1
LU - Lussemburgo 1
NG - Nigeria 1
PA - Panama 1
PT - Portogallo 1
TH - Thailandia 1
TW - Taiwan 1
Totale 12.698
Salva come PNG Salva come JPEG
Città #
Chandler 1.123
Singapore 1.036
Hong Kong 668
Millbury 473
Santa Clara 451
Amsterdam 404
Princeton 302
Jacksonville 271
Naples 267
Nanjing 258
Ashburn 206
Wilmington 197
Napoli 138
Boston 134
Beijing 123
Des Moines 122
Ottawa 112
Helsinki 86
Woodbridge 84
Lawrence 78
Nanchang 76
Seattle 60
Hebei 58
Houston 48
Munich 45
Shenyang 42
Rome 39
Ann Arbor 37
Norwalk 34
Tianjin 32
Jiaxing 31
Kronberg 31
Changsha 28
Falls Church 28
Falkenstein 27
San Mateo 26
Boardman 24
Dublin 20
Moscow 20
Kunming 19
Pune 18
Redwood City 18
Ardabil 17
Indiana 17
Shanghai 16
Dong Ket 15
Lappeenranta 15
Toronto 15
New York 14
San Francisco 14
Afragola 13
Cagliari 13
London 13
Redmond 13
Dallas 12
Fairfield 12
Frankfurt am Main 12
Brno 11
Casoria 11
Los Angeles 11
Marigliano 11
Augusta 10
Milan 10
Montreal 10
Bari 9
Dearborn 9
Jinan 9
Ningbo 9
Portici 9
Hangzhou 8
Lanzhou 8
Washington 8
Brussels 7
Molina de Segura 7
Catania 6
Columbus 6
Leawood 6
Paris 6
Sandston 6
Villa Literno 6
Buffalo 5
Caserta 5
Changchun 5
Livorno 5
Menlo Park 5
Mexico City 5
Padova 5
Tappahannock 5
Turin 5
Zhengzhou 5
Arzano 4
Bologna 4
Cairo 4
Fuzhou 4
Guangzhou 4
Mexico 4
Modena 4
Mountain View 4
Mugnano Di Napoli 4
Nuremberg 4
Totale 7.788
Salva come PNG Salva come JPEG
Nome #
Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age 89
Spot-light on microbiota in obesity and cancer 82
Flavor perception test: evaluation in patients with Kallmann syndrome 81
Cabergoline plus lanreotide for ectopic Cushing's syndrome. 76
Short-term effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency 76
Antipituitary antibodies in idiopathic hyperprolactinemic patients 72
The 17β-hydroxysteroid dehydrogenase type 3 deficiency: a case report of an 18-year patient and review of the literature. 69
"Realizzazione, sperimentazione, messa a punto, sviluppo e reindustrializzazione di un metodo biomolecolare integrato (“hepatochip”) per la caratterizzazione diagnostica e prognostica di lesioni epatiche correlate o meno ad infezioni virali" 68
Effect of gender and gonadal status on the long-term response to somatostatin analogue treatment in acromegaly 67
Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism 67
Weekly clodronate treatment prevents bone loss and vertebral fractures in womenwith subclinical Cushing's syndrome. 67
Neuropsychiatric disorders in Cushing's syndrome. 65
Adverse events associated with somatostatin analogs in acromegaly. 64
Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours 64
The Treatment of Cushing's Disease. 63
Sulfur amino acids in Cushing's disease: insight in homocysteine and taurine levels in patients with active and cured disease 63
A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patients 62
Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patients 62
Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance 61
Reduced bone mineral density in glycogen storage disease type III: Evidence for a possible connection between metabolic imbalance and bone homeostasis 61
Selenium supplementation modulates apoptotic processes in thyroid follicular cells 59
The treatment with growth hormone receptor antagonist in acromegaly: effect on vascular structure and function in patients resistant to somatostatin analogues. 58
The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients 57
The environment and male reproduction: The effect of cadmium exposure on reproductive functions and its implication in fertility 57
Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation. 56
Increased prevalence of thyroid autoimmunity and hypothyroidism in patients with glycogen storage disease type I 56
Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy. 56
The GH-IGF system in amyotrophic lateral sclerosis: correlations between pituitary GH secretion capacity, insulin-like growth factors and clinical features. 56
Accordi di programma "Piattaforme tecnologiche avanzate per la definizione di nuovi biomarkers e bersagli molecolari in vettori nanotecnologici per la diagnosi e la terapia di neoplasie umane" 56
The effect of FT500 Plus® on ovarian stimulation in PCOS women 56
Air pollution and female fertility: A systematic review of literature 56
A New Clinical Model to Estimate the Pre-Test Probability of Cushing’s Syndrome: The Cushing Score 56
Recombinant thyrotropin-induced orbital uptake of [111In-diethylenetriamine-pentacetic acid-D-Phe1]octreotide in a patient with inactive Graves' ophthalmopathy. 55
Effects of long-term combined treatment with somatostatin analogues and pegvisomant on cardiac structure and performance in acromegaly 55
The role of vitamin D in male fertility: A focus on the testis 55
The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis. 54
Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status 54
Hypertension in acromegaly and in the normal population: prevalence and determinants 53
Comment on Azmahani et al. "Steroidogenic enzymes, their related transcription factors and nuclear receptors in human sebaceous glands under normal and pathological conditions" 53
Erratum to: The treatment with pasireotide in Cushing’s disease: effects of long–term treatment on tumor mass in the experience of a single center (Endocrine, (2015), 50, (725-740) DOI 10.1007/s12020-015-0557-2) 53
Circadian rhythm of glucocorticoid administration entrains clock genes in immune cells: a DREAM trial ancillary study 53
CONVENTIONAL AND NUCLEAR MEDICINE IMAGING IN ECTOPIC CUSHING'S SYNDROME: A SYSTEMATIC REVIEW. 52
Cushing's syndrome 52
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE). 52
Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly. 51
Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system. 51
The treatment with pasireotide in Cushing's disease: effects of long-term treatment on tumor mass in the experience of a single center. 51
Adrenal Mass: Insight Into Pathogenesis and a Common Link With Insulin Resistance 51
First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial. 50
Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission 50
Pause: Premature ejaculation actual use sefety and effectiveness study. Studio prospettico osservazionale su pazienti con eiaculazione precoce trattati con Priligy o terapie alternative. 50
[Chronic kidney disease: fertility and sexuality] 50
Metabolic alterations and cardiovascular outcomes of cortisol excess 50
CORTISOL CIRCADIAN RHYTHM AND INSULIN RESISTANCE IN MUSCLE: EFFECT OF DOSING AND TIMING OF HYDROCORTISONE EXPOSURE ON INSULIN SENSITIVITY IN SYNCHRONIZED MUSCLE CELLS 50
Prevalence of the metabolic syndrome in moderately-severely obese subjects with and without growth hormone deficiency. 49
The Glucocorticoid Analog Dexamethasone Alters the Expression and the Distribution of Dopamine Receptors and Enkephalin within Cortico-subcortical Regions. 49
"Dopamine receptor expression and role of dopamine D2 receptor activation in pituitary and adrenaltumors”. 49
Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit 49
Complications of Cushing's syndrome: State of the art 49
Bisphenol A: An emerging threat to female fertility 49
Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma 48
Cushing's syndrome: aftermath of the cure. 48
Cabergoline use for pituitary tumors and valvular disorders. 48
The role of inferior petrosal sinus sampling in ACTH-dependent Cushing's syndrome:review and joint opinion statement by members of the Italian Society for Endocrinology, Italian Society for Neurosurgery, and Italian Society for Neuroradiology 48
The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma 48
Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial. 48
Acromegalic axial arthropathy: a clinical case-control study 47
A longitudinal study of vasopressin cell antibodies, posterior pituitary function, and magnetic resonance imaging evaluations in subclinical autoimmune central diabetes insipidus 47
Octreotide-LAR vs lanreotide-SR as first-line therapy for acromegaly: A retrospective, comparative, head-to-head study 47
Germline polymorphisms of the VEGF-pathway predict recurrence in non-advanced differentiated thyroid cancer 47
17 beta hyrossisteroid dehydrogenase type 3 deficiency : a new case of a rare disease with uncommon gene mutation 46
Pituitary tumors and pregnancy: the interplay between a pathologic condition and a physiologic status. 46
Pegvisomant in acromegaly: why, when, how 45
Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly 45
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males 45
Complete disappearance of a GH-secreting pituitary macroadenoma in a patient with acromegaly: effect of treatment with lanreotide Autogel and consequence of treatment withdrawal. 45
Effects of initial therapy for five years with somatostatin analogs foracromegaly on growth hormone and insulin-like growth factor-I levels, tumorshrinkage, and cardiovascular disease: a prospective study. 45
Evaluation of the retinal nerve fibre layer and ganglion cell complex thickness in pituitary macroadenomas without chiasmal compression. 45
Pathophysiology of diabetes mellitus in Cushing's syndrome. 44
The medical treatment of Cushing's disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery. 44
Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities 44
Pasireotide treatment reduces cardiometabolic risk in Cushingâ s disease patients: an Italian, multicenter study 44
Effect of combined treatment with a pan-PI3K inhibitor or an isoform-specific PI3K inhibitor and everolimus on cell proliferation in GH-secreting pituitary tumour in an experimental setting 44
Growth hormone excess with onset in adolescence: clinical appearance and long-term treatment outcome 43
Cardiovascular disease in Cushing's syndrome: heart versus vasculature. 43
Quality of Life in Patients with Cushing's Disease: A Modern Approach 43
Cushing’s disease: the burden of illness 43
Correlation between Morphometric parameters and chromatin fragmentation in spermatozoa of Canis familiaris. 43
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 43
Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients 42
Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency 42
Growth hormone nadir during oral glucose load depends on waist circumference, gender and age: normative data in 231 healthy subjects. 42
Glucose tolerance and somatostatin analog treatment in acromegaly: a 12-monthstudy. 42
Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study. 42
Dual targeting of PIK3/AKT/mTOR and IGF1/KRAS/BRAF pathways in an in vitro model of ovarian cancer: strategies for cell proliferation control 42
Severe impact of late diagnosis of congenital adrenal hyperplasia on gender identity, sexual orientation and function: case report and review of the literature 41
Early vascular alterations in acromegaly 41
Cardiovascular alterations in adult GH deficiency 41
The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications 41
Short-term suppression of GH and IGF-I levels improves gonadal function and sperm parameters in men with acromegaly 40
Totale 5.269
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.407
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.407
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020419 0 0 0 0 0 0 7 13 20 48 139 192
2020/2021768 19 36 94 50 77 156 46 8 83 32 134 33
2021/20222.214 37 7 10 25 54 215 29 61 372 120 376 908
2022/20232.709 409 227 75 213 329 262 27 230 374 414 112 37
2023/20241.773 86 271 239 142 80 115 49 190 27 40 314 220
2024/20253.237 636 759 104 97 256 586 799 0 0 0 0 0
Totale 13.306